Candice Brett, Joins Pittsburgh-Based Contract Research Organization, Clinical Research Strategies, LLC as Manager of Business Operations

Pittsburgh, PA – November 9, 2021. Clinical Research Strategies, LLC (“CRS”), a Pittsburgh-area-based, US-owned and operated contract research organization (CRO) and executive management consultancy for the life sciences industry is pleased to announce the addition of Candice Brett, Manager of Business Operations, to the firm. Ms. Brett is an experienced business manager and accounting professional with more than 15 years in customer- and service-oriented industries.

Ms. Brett earned her bachelors of science (BS) in business management from North Carolina State University. She has held various roles with increasing responsibility, including in financial consulting, billing, bank reconciliation, and financial reporting for small, mid-size, and large companies. Candice and her family spend significant time giving back to their community, including with food banks and other mentoring for those less fortunate.  Ms. Brett lives in North Carolina with access to numerous CRS clients, including emerging life sciences companies and other existing partnerships.

Candice Brett

Alethea Wieland, President and Co-founder says, “We are very lucky to have Candice join us as our back-office, employment, tax, accounting, and complex contracting needs grow with new client accounts.” CRS CEO and Chief Quality and Regulatory Officer, David Link, MBA, adds, “Candice adds that genuine extra care and attention to our workforce and epitomizes trust that sets us apart from others in the industry.”

About Clinical Research Strategies, LLC: CRS is a specialty CRO and executive management consulting firm that fits-for-purpose veteran life sciences executives, attorneys, regulatory scientists and strategists, clinical operations, project management, quality assurance engineers, and sales and marketing teams to take on the biggest challenges for start-up and mid-sized life sciences companies, many of whom are developing novel, first-in-class drugs, biologics, diagnostics and medical devices, or software as a medical device (SaMD). Service areas are clinical trials, Functional Service Provider (FSP) models, selection and management of CROs, regulatory compliance strategy and submissions, QMS, EU MDR and GDPR, rescue trials, TMF, risk mitigation and remediation, training high-performing teams, staffing solutions, and decentralized trials.

Indications represented are precision medicine, immuno-oncology, central nervous system, infectious diseases, respiratory diseases, orthopedics, de novo devices, digital health and mobile apps, reproductive health, regenerative medicine, cardiology, major depressive disorder, opioid-sparing pain, cannabis, radiology, and critical care. CRS is a qualified service provider for federal grants.

CRS is an inclusive employer and does not discriminate in employment on the basis of race, color, religion, sex, gender identity, national origin, political affiliation, sexual orientation, marital status, disability, genetic information, age, education, membership in an employee organization, parental status, military service, or other non-merit factor. CRS does not tolerate censorship, surveillance, bullying, intimidation, retaliation, discrimination, or harassment of any kind.

# # #

Media Contact:
Ron MacDonald
Step2 Branding & Design
+1 724.814.4067

Alethea Wieland, President and Founder
Clinical Research Strategies, LLC
+1 724.272.1245


Download this press release as a PDF.

Share This